Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimecrolimus cream 1% for adult perioral dermatitis
2005-002058-23Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in perioral dermatitis comparing Elidel 1% cream with Vehicle control (2 arms). Primary endpoint: Primary efficacy endpoint. Started Dec 2005; status: completed.
02
Drugs
pimecrolimus
03
Conditions
perioral dermatitis
Beyond the preview
Go deeper on 2005-002058-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002058-23.